Three Cases of Ticlopidine-induced Cholestatic Hepatitis.
- Author:
Jee Hyun KIM
1
;
Young Ju KWON
;
Jung Eun KIM
;
Ka Eun WOO
;
Yong Jae KIM
Author Information
1. Department of Neurology, Ewha Womans University Hospital, Korea. brain930@ewha.ac.kr
- Publication Type:Case Report
- Keywords:
Ticlopidine;
Cholestatic hepatitis
- MeSH:
Adenosine Diphosphate;
Hepatitis*;
Humans;
Jaundice;
Skin;
Substance-Related Disorders;
Ticlopidine
- From:Journal of the Korean Neurological Association
2002;20(4):434-436
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Ticlopidine hydrochloride is world-wide used antiplatelet agent that inhibit ADP pathway. Its clinical side effects are the change of the blood picture, allergic skin reaction and gastrointestinal symptoms. We report three patients with severe cholestatic hepatitis caused by ticlopidine. They developed jaundice about 20days after taking ticlopidine (500 mg/day). Infectious and immunological etiologies were excluded by serology. There was no history of alcohol or drug abuse. Their symptoms were gradually subsided for a few months after discontinuing ticlopidine.
